June 1, 2017 — QUBYX Software Technologies Inc. received U.S. Food and Drug Administration (FDA) clearance for its DICOM calibration tool and a Dell UP3017 monitor. The monitor is used for viewing medical images such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound and others, as well as for review and diagnostics by trained medical practitioners.

An industry expert from Vital Images, Inc. (Vital) is participating in a discussion with the healthcare community on specialized workflow and efficiency challenges at the Society for Imaging Informatics in Medicine (SIIM) 2017 annual meeting, June 1-3 in Pittsburgh.

Siemens Healthineers and the Fraunhofer Institute for Medical Image Computing MEVIS announced the formation of a new research alliance to develop decision support systems for physicians based on deep machine learning. The partners will discuss their joint efforts at the German Radiology Congress, May 24-27 in Leipzig, Germany.

Carestream Health has received an Innovative Technology contract from Vizient Inc. for its Carestream OnSight 3-D Extremity System. Vizient is among the largest member-driven healthcare performance improvement companies in the country.

Scientists from the Netherlands and Russia designed and tested a new metasurface-based technology for enhancing the local sensitivity of magnetic resonance imaging (MRI) scanners on humans for the first time. The metasurface consists of thin resonant strips arranged periodically. Placed under a patient's head, it provided much higher signals from the local brain region.

MIM Software Inc. recently announced significant updates to its MIM Encore solution for viewing nuclear medicine images. The vendor-neutral application offers viewing of positron emission tomography (PET)/computed tomography (CT), single photon emission computed tomography (SPECT)/CT, PET/magnetic resonance imaging (MRI) and general nuclear medicine images. Physicians and technologists can streamline the nuclear medicine workflow by viewing and processing images in tandem using this single-platform solution.

The American Society for Radiation Oncology (ASTRO) released a statement last week strongly opposing the extensive cuts to cancer research and Medicaid funding in the Fiscal Year 2018 budget released by the White House. The association said these substantial reductions in support for medical research and care would destabilize the progress toward finding cures and negatively impact cancer patients across the country.

Kubtec announced recently that the U.S. Patent Office has granted the company an additional patent for its technology used for breast specimen imaging using 3-D tomosynthesis.

Patients who were implanted with the BioZorb 3-D bioabsorbable marker during their lumpectomy could be treated with smaller radiation volumes than patients who did not receive the marker, according to new research. The findings were presented at the recent American Society of Breast Surgeons (ASBrS) annual meeting, April 26-30 in Las Vegas. The difference in volumes was statistically significant.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now